OMECAMTIV MECARBIL TABLET

Provided herein are tablet formulations comprising a core comprising omecamtiv mecarbil, a pharmaceutically acceptable salt thereof, or a pharmaceutically acceptable hydrate of a pharmaceutically acceptable salt thereof; a filler; a binder; a glidant; and a lubricant; and a film coating on the core,...

Full description

Saved in:
Bibliographic Details
Main Authors KIANG, Yuan-Hon, BI, Mingda, LOU, Hao
Format Patent
LanguageEnglish
Published 23.03.2023
Subjects
Online AccessGet full text

Cover

Loading…
Abstract Provided herein are tablet formulations comprising a core comprising omecamtiv mecarbil, a pharmaceutically acceptable salt thereof, or a pharmaceutically acceptable hydrate of a pharmaceutically acceptable salt thereof; a filler; a binder; a glidant; and a lubricant; and a film coating on the core, the film coating comprising a modified-release polymer and a pore former. Also provided is a process for making a tablet formulation and a method of treating cardiovascular conditions, such as heart failure, using the tablet formulation.
AbstractList Provided herein are tablet formulations comprising a core comprising omecamtiv mecarbil, a pharmaceutically acceptable salt thereof, or a pharmaceutically acceptable hydrate of a pharmaceutically acceptable salt thereof; a filler; a binder; a glidant; and a lubricant; and a film coating on the core, the film coating comprising a modified-release polymer and a pore former. Also provided is a process for making a tablet formulation and a method of treating cardiovascular conditions, such as heart failure, using the tablet formulation.
Author KIANG, Yuan-Hon
BI, Mingda
LOU, Hao
Author_xml – fullname: KIANG, Yuan-Hon
– fullname: BI, Mingda
– fullname: LOU, Hao
BookMark eNrjYmDJy89L5WSQ9Pd1dXb0DfEMUwAxgpw8fRRCHJ18XEN4GFjTEnOKU3mhNDeDsptriLOHbmpBfnxqcUFicmpeakl8aLCRgZGxgaWBsaWho6ExcaoAX_QijA
ContentType Patent
DBID EVB
DatabaseName esp@cenet
DatabaseTitleList
Database_xml – sequence: 1
  dbid: EVB
  name: esp@cenet
  url: http://worldwide.espacenet.com/singleLineSearch?locale=en_EP
  sourceTypes: Open Access Repository
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
Chemistry
Sciences
ExternalDocumentID US2023090391A1
GroupedDBID EVB
ID FETCH-epo_espacenet_US2023090391A13
IEDL.DBID EVB
IngestDate Fri Jul 19 14:39:28 EDT 2024
IsOpenAccess true
IsPeerReviewed false
IsScholarly false
Language English
LinkModel DirectLink
MergedId FETCHMERGED-epo_espacenet_US2023090391A13
Notes Application Number: US202117798531
OpenAccessLink https://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20230323&DB=EPODOC&CC=US&NR=2023090391A1
ParticipantIDs epo_espacenet_US2023090391A1
PublicationCentury 2000
PublicationDate 20230323
PublicationDateYYYYMMDD 2023-03-23
PublicationDate_xml – month: 03
  year: 2023
  text: 20230323
  day: 23
PublicationDecade 2020
PublicationYear 2023
RelatedCompanies Amgen Inc
RelatedCompanies_xml – name: Amgen Inc
Score 3.4643772
Snippet Provided herein are tablet formulations comprising a core comprising omecamtiv mecarbil, a pharmaceutically acceptable salt thereof, or a pharmaceutically...
SourceID epo
SourceType Open Access Repository
SubjectTerms HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
Title OMECAMTIV MECARBIL TABLET
URI https://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20230323&DB=EPODOC&locale=&CC=US&NR=2023090391A1
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfR3LSsNAcChV1JtWxWqVgJJbsMkmMR6CJJuEVpqmtEnprWSSFASppU3x952NqfbU2-wOzD5gXjuPBXhCdSECmplSdHOmCIGnoJ6hkrK8a6WmiaolCoXDodlL9PeZMWvA564WpuoT-l01RySOyojfy0per_4fsbwqt3LzjB809fUWxLYn194x2dNMY7Ln2v4o8iIuc24nE3k4_sW9inboDvlKR8KQFp32_akr6lJW-0olOIfjEdFblhfQKJYtOOW7v9dacBLWIW8Ca-7bXEI7Cn3uhHF_Kglg7PYHUuy4Az--gsfAj3lPoTXmf0eaJ5P9DbFraJKzX9yA9JIzpiGqOjLUSfYg03JyUayFjlqaGUYbOoco3R5G38GZGIocKo11oFmut8U9KdUSH6q7-AGiMXbe
link.rule.ids 230,309,786,891,25594,76903
linkProvider European Patent Office
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV1LS8NAEB5KFetNq2K1akDJLdhkkzQeguRJonmUNim9hWySgiC12Ih_39mYak-9DTsw-4CZ2W_nsQAPVFyygGYhVKOSCMzgCVQuqJCTcqTlqkpFjRUKh5HqpfLLQll04H1bC9P0Cf1umiOiRhWo73Vjr9f_j1h2k1u5eaRvOPTx7Ca6zbfoGO_TRCK8berOJLZji7csPZ3x0fSX98TaoRuIlQ7GCAobsDQ3WV3KetepuCdwOEF5q_oUOtWqDz1r-_daH47CNuSNZKt9mzMYxKFjGWHizzlGTE0_4BLDDJzkHO5dJ7E8AefI_raUpbPdBZEL6CLYry6BG5eESJSKMiVURttDiVQiRNGWMpXyQlEGMNwn6Wo_-w56XhIGWeBHr9dwzFgsn0oiQ-jWn1_VDTrYmt425_IDVdt5yA
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Apatent&rft.title=OMECAMTIV+MECARBIL+TABLET&rft.inventor=KIANG%2C+Yuan-Hon&rft.inventor=BI%2C+Mingda&rft.inventor=LOU%2C+Hao&rft.date=2023-03-23&rft.externalDBID=A1&rft.externalDocID=US2023090391A1